Combination of Irinotecan and Temozolomide in Children With Brain Tumors.

NCT00404495 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

83

Enrollment

INDUSTRY

Sponsor class

Conditions

Glioma
Medulloblastoma

Interventions

DRUG: Irinotecan
DRUG: Temozolomide

Sponsor

Pfizer